Sartorius Competitors
Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
---|---|---|---|---|---|---|---|---|
AZN | AstraZeneca PLC | Outperform |
17
|
£119.88 | £165.99 | 35.93% | 16 | £186.43B |
TMO | Thermo Fisher Scientific | Outperform |
10
|
$573.60 | $591.94 | 7.22% | 1 | $218.24B |
ROG | Roche Holding | Hold |
16
|
CHF221.00 | CHF307.83 | 23.30% | 9 | CHF178.76B |
DHR | Danaher | Outperform |
10
|
$246.58 | $260.33 | 9.50% | 4 | $182.06B |
PH | Parker-Hannifin Corp | Outperform |
10
|
$553.64 | $548.76 | 7.47% | 7 | $68.65B |
MRK | Merck KGaA | Outperform |
18
|
151.75€ | 190.06€ | 20.59% | 4 | 63.48€B |
BDX | Becton Dickinson and Co | Outperform |
9
|
$231.55 | $284.47 | 19.84% | 8 | $67.64B |
A | Agilent Technologies | Outperform |
10
|
$137.74 | $138.82 | 9.99% | 10 | $38.90B |
BIIB | Biogen | Outperform |
10
|
$208.90 | $299.62 | 38.10% | 13 | $29.36B |
BAYN | Bayer | Hold |
5
|
27.40€ | 45.15€ | 9.49% | 4 | 25.86€B |
MTD | Mettler-Toledo International | Hold |
13
|
$1.24k | $1.12k | -0.65% | 0 | $25.42B |
STE | STERIS | Outperform |
13
|
$203.90 | $238.33 | 18.20% | 4 | $19.71B |
ENTG | Entegris | Outperform |
18
|
$132.60 | $116.12 | 10.86% | 11 | $18.42B |
RGEN | Repligen | Outperform |
16
|
$166.58 | $187.18 | 30.57% | 12 | $8.99B |
GETI B | Getinge AB | Outperform |
18
|
kr235.10 | kr226.10 | -3.02% | 3 | kr64.03B |
3355 | Kuriyama Holdings | Outperform |
17
|
¥1.22k | ¥0.00 | 7.41% | 0 | ¥18.46B |